FDA guidance on cardiovascular risk of antidiabetic therapies: One decade later

Diabetes Obes Metab. 2019 May;21(5):1079-1080. doi: 10.1111/dom.13669. Epub 2019 Mar 15.

Author

Clifford J Bailey¹

Affiliation

¹ Life and Health Sciences, Aston University, Birmingham, UK.

PMID: 30762280
DOI: 10.1111/dom.13669

No abstract available

Publication types

Comment

MeSH terms

Cardiovascular Diseases*
Cardiovascular System*
Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents
Risk Factors

Substances

Hypoglycemic Agents